ゲノミクス向けAIの世界市場：提供別、機能別、用途別、配信モード別、エンドユーザー別 - 予測（～2029年）

世界のゲノミクス向けAIの市場規模は、2022年から2029年までの予測期間中に42.8%のCAGRで成長し、2029年までに62億2,000万米ドルに達すると予測されています。市場の成長を後押しする主な要因には、創薬・開発のターンアラウンドタイム短縮への注目の高まり、ヘルスケア/ゲノミクスにおけるAI利用の増加、AIへの投資の増加、新興のスタートアップ企業や、個別化／精密医療における機械学習（ML）の採用の高まりなどが挙げられます。

当レポートでは、世界のゲノミクス向けAI市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、競合情勢、提供別・機能別・用途別・配信モード別・エンドユーザー別・地域別の分析、および企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場エコシステム
• 通貨
• 主な利害関係者

第2章 調査手法

• 調査プロセス
• データ収集と検証
  • 2次調査
  • 1次調査
• 市場評価
  • 市場規模の見積もり
  • 市場シェア分析
• 調査の前提条件
• 調査の制限

第3章 エグゼクティブサマリー

第4章 市場の洞察

• イントロダクション
• 促進要因
  • 創薬におけるターンアラウンドタイムの短縮への関心の高まり
  • ゲノミクスへの投資の増加
  • ゲノミクスにおけるAIの必要性の高まりとその応用
• 抑制要因
  • 人工知能をゲノミクスに統合するための限定的な資源
• 機会
  • 新興国
  • 個別化医療の開発に対する関心の高まり
• 課題
  • ゲノミクスソフトウェアに関するあいまいな規制ガイドライン
  • 大量のゲノム配列決定データの保存・不十分なセキュリティ
• COVID-19の影響

第5章 世界のゲノミクス向けAI市場：提供別

• イントロダクション
• ソフトウェア
• サービス

第6章 世界のゲノミクス向けAI市場：配信モード別

• イントロダクション
• クラウド・Webベースモード
• オンプレミスモード

第7章 世界のゲノミクス向けAI市場：機能別

• イントロダクション
• ゲノム配列決定
• 遺伝子編集
• その他

第8章 世界のゲノミクス向けAI市場：用途別

• イントロダクション
• 創薬・開発
• 精密医療
• 診断
• その他

第9章 世界のゲノミクス向けAI市場：エンドユーザー別

• イントロダクション
• 製薬・バイオテクノロジー企業
• 学術・研究機関
• その他

第10章 ゲノミクス向けAI市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
• 中東・アフリカ

第11章 競合情勢

• イントロダクション
• 主要な成長戦略
• 競合ベンチマーキング
• 市場シェア分析（2021年）
  • NVIDIA Corporation
  • Microsoft Corporation
  • Illumina, Inc.

第12章 企業プロファイル（事業概要、財務概要、ソリューションポートフォリオ、戦略的展開）

• Microsoft Corporation
• NVIDIA Corporation
• Deep Genomics Incorporated
• Fabric Genomics, Inc.
• Data4cure, Inc.
• Predictive Oncology Inc.
• Emedgene Technologies Ltd
• Congenica Ltd.
• Tempus Labs, Inc.
• SOPHiA GENETICS SA
• Illumina, Inc.
• BenevolentAI Limited

第13章 付録

List of Tables

• Table 1 Global AI in Genomics Market Drivers: Impact Analysis (2022-2029)
• Table 2 Global AI in Genomics Market Restraints: Impact Analysis (2022-2029)
• Table 3 Global AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 4 Global Artificial Intelligence in Genomics Software Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 5 Global AI in Genomics Services Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 6 Global AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 7 Global AI in Genomics Market Size for Cloud & Web-Based Mode, by Country/Region, 2020-2029 (USD Million)
• Table 8 Global AI in Genomics Market Size for On-Premise Mode, by Country/Region, 2020-2029 (USD Million)
• Table 9 Global AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 10 Global AI in Genomics Market Size for Genome Sequencing, by Country/Region, 2020-2029 (USD Million)
• Table 11 Global AI in Genomics Market Size for Gene Editing, by Country/Region, 2020-2029 (USD Million)
• Table 12 Global AI in Genomics Market Size for Other Functionalities, by Country/Region, 2020-2029 (USD Million)
• Table 13 Global AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 14 Global AI in Genomics Market Size for Drug Discovery & Development, by Country/Region, 2020-2029 (USD Million)
• Table 15 Global AI in Genomics Market Size for Precision Medicine, by Country/Region, 2020-2029 (USD Million)
• Table 16 Global Artificial Intelligence in Genomics Market Size for Diagnostics, by Country/Region, 2020-2029 (USD Million)
• Table 17 Global AI in Genomics Market Size for Other Applications, by Country/Region, 2020-2029 (USD Million)
• Table 18 Global AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 19 Global AI in Genomics Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2020-2029 (USD Million)
• Table 20 Global AI in Genomics Market Size for Academic & Research Institutes, by Country/Region, 2020-2029 (USD Million)
• Table 21 Global AI in Genomics Market Size for Other End Users, by Country/Region, 2020-2029 (USD Million)
• Table 22 Global AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 23 North America: AI in Genomics Market Size, by Country, 2020-2029 (USD Million)
• Table 24 North America: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 25 North America: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 26 North America: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 27 North America: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 28 North America: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 29 U.S.: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 30 U.S.: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 31 U.S.: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 32 U.S.: Artificial Intelligence in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 33 U.S.: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 34 Canada.: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 35 Canada: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 36 Canada: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 37 Canada: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 38 Canada.: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 39 Europe: AI in Genomics Market Size, by Country/Region, 2022-2029 (USD Million))
• Table 40 Europe: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 41 Europe: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 42 Europe: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 43 Europe: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 44 Europe: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 45 Germany: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 46 Germany: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 47 Germany: Artificial Intelligence in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 48 Germany: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 49 Germany: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 50 France: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 51 France: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 52 France: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 53 France: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 54 France: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 55 U.K.: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 56 U.K.: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 57 U.K.: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 58 U.K.: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 59 U.K.: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 60 Italy: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 61 Italy: Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 62 Italy: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 63 Italy: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 64 Italy: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 65 Spain: AI in Genomics Market Size, by Offerings, 2020-2029 (USD Million)
• Table 66 Spain: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 67 Spain: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 68 Spain: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 69 Spain: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 70 Rest of Europe: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 71 Rest of Europe: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 72 Rest of Europe: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 73 Rest of Europe: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 74 Rest of Europe: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 75 Asia-Pacific: AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 76 Asia-Pacific: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 77 Asia-Pacific: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 78 Asia-Pacific: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 79 Asia-Pacific: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 80 Asia-Pacific: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 81 China: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 82 China: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 83 China: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 84 China: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 85 China: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 86 Japan: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 87 Japan: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 88 Japan: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 89 Japan: AI in Market Size, by Application, 2020-2029 (USD Million)
• Table 90 Japan: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 91 India: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 92 India: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 93 India: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 94 India: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 95 India: Artificial Intelligence in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 96 Rest of Asia Pacific: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 97 Rest of Asia Pacific: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 98 Rest of Asia Pacific: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 99 Rest of Asia Pacific: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 100 Rest of Asia Pacific: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 101 Latin America: AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 102 Latin America: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 103 Latin America: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 104 Latin America: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 105 Latin America: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 106 Latin America: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 107 Brazil: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 108 Brazil: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 109 Brazil: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 110 Brazil: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 111 Brazil: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 112 Mexico: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 113 Mexico: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 114 Mexico: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 115 Mexico: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 116 Mexico: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 117 Rest of Latin America: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 118 Rest of Latin America: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 119 Rest of Latin America: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 120 Rest of Latin America: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 121 Rest of Latin America: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 122 Middle East & Africa: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
• Table 123 Middle East & Africa: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
• Table 124 Middle East & Africa: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
• Table 125 Middle East & Africa: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
• Table 126 Middle East & Africa: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
• Table 127 Recent Developments, by Company, 2020-2022

List of Figures

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
• Figure 6 Market Size Estimation
• Figure 7 Global AI in Genomics Market Size, by Offering, 2022-2029 (USD Million)
• Figure 8 Global Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2022-2029 (USD Million)
• Figure 9 Global AI in Genomics Market Size, by Functionality, 2022-2029 (USD Million)
• Figure 10 Global AI in Genomics Market Size, by Application, 2022-2029 (USD Million)
• Figure 11 Global AI in Genomics Market Size, by End User, 2022-2029 (USD Million)
• Figure 12 Global AI in Genomics Market, by Geography
• Figure 13 Market Dynamics: AI in Genomics Market
• Figure 14 Global Rise in the Number of Personalized Medicines, 2008-2020
• Figure 15 Global AI in Genomics Market Size, by Offering, 2022 Vs. 2029 (USD Million)
• Figure 16 Global AI in Genomics Market Size, by Delivery Mode, 2022 Vs. 2029 (USD Million)
• Figure 17 Global AI in Genomics Market Size, by Functionality, 2022 Vs. 2029 (USD Million)
• Figure 18 Global AI in Genomics Market Size, by Application, 2022 Vs. 2029 (USD Million)
• Figure 19 Global AI in Genomics Market Size, by End User, 2022 Vs. 2029 (USD Million)
• Figure 20 Global AI in Genomics Market Size, by Geography, 2022-2029 (USD Million)
• Figure 21 North America: AI in Genomics Market Snapshot
• Figure 22 Europe: AI in Genomics Market Snapshot
• Figure 23 Asia-Pacific: AI in Genomics Market Size Snapshot
• Figure 24 Latin America: AI in Genomics Market Size Snapshot
• Figure 25 Key Growth Strategies Adopted by Leading Players, 2020-2022
• Figure 26 AI in Genomics Market: Competitive Benchmarking by Functionality
• Figure 27 AI in Genomics Market: Competitive Benchmarking by Geography
• Figure 28 Market Share Analysis: AI in Genomics Market, 2021
• Figure 29 Microsoft Corporation: Financial Overview (2022)
• Figure 30 NVIDIA Corporation: Financial Overview (2022)
• Figure 31 Predictive Oncology Inc.: Financial Overview (2021)
• Figure 32 SOPHiA GENETICS SA: Financial Overview (2021)
• Figure 33 Illumina, Inc.: Financial Overview (2021)
• Figure 34 BenevolentAI Limited: Financial Overview (2021)

The AI in genomics market is expected to reach $6.22 billion by 2029, at a CAGR of 42.8% from 2022 to 2029.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of the AI in genomics market is attributed to the rising focus on reducing turnaround time in drug discovery & development, increasing use of AI in healthcare/genomics, and growing investments in AI. In addition, emerging start-ups and the rising adoption of machine learning (ML) in personalized/precision medicine are likely to offer opportunities for market growth.

Based on offering, in 2022, the software segment is estimated to account for the largest share of the market. The key factors attributed to this segment's large market share are the growing adoption of AI in healthcare/genomics and the advancements in AI algorithms to analyze huge amounts of genetic datasets. For instance, in April 2022, MedGenome (U.S.) launched an AI-enabled variant interpretation software suit, VarMiner, to help clinicians, genome analysts, and molecular geneticists interpret and report variants. In the other instance, in October 2020, Fabric Genomics (U.S.) launched Fabric GEM to accelerate genetic disease diagnosis and provide comprehensive clinical-decision support.

The AI in genomics market is segmented by offering (software, services), delivery mode (on-premises, cloud & web-based), functionality (genome sequencing, gene editing, other functionalities), application (drug discovery and development, precision medicine, diagnostics, and other applications), end user (pharmaceutical & biopharmaceutical companies, academic & research institutes, and other end users), and geography. The study also evaluates industry competitors and analyzes their market shares at global and regional levels.

Based on functionality, in 2022, the genome sequencing segment is estimated to account for the largest share of the market. The factors attributing to the large market share of this segment are the increasing adoption of AI in genome sequencing studies and the growing R&D related to COVID-19.

Based on application, the market is segmented into drug discovery and development, precision medicine, diagnostics, and other applications. In 2022, the drug discovery and development segment is estimated to account for the largest share of the market. The key factors attributing to the large market share of this segment are the growing adoption of AI algorithms in drug discovery and the growing collaboration between pharmaceutical/biopharmaceutical companies and companies that provide AI solutions.

Based on end user, the pharmaceutical & biopharmaceutical companies segment is estimated to account for the largest share of the market. These companies use AI algorithms to speed up drug discovery. Furthermore, the increasing burden of chronic and infectious diseases is burdening pharmaceutical companies to speed up drug discovery. Thus, the highest adoption of AI in genomics solutions by pharmaceutical and biopharmaceutical companies contributes to this segment's large market share.

An in-depth analysis of the geographical scenario of the AI in genomics provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2022, North America is estimated to account for the largest share of the AI in genomics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The increasing research initiatives in genomics, the availability of infrastructure for genomics research and AI, and the growing adoption of AI in precision medicine to meet the increasing market demand are the factors contributing to the large market share of this region.

Some of the key players operating in the global AI in genomics are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Scope of the Report:

Global AI in Genomics Market, by Offering

• Software
• Services

Global AI in Genomics Market, by Delivery Mode

• On-premises
• Cloud & Web-Based Mode

Global AI in Genomics Market, by Functionality

• Genome Sequencing
• Gene Editing
• Other Functionalities

Note: Other functionalities include pharmacogenomics and predictive gene testing.

Global AI in Genomics Market, by Application

• Drug Discovery & Development
• Precision Medicine
• Diagnostics
• Other Applications

Note: Other applications include agriculture, pharmacology, and animal health.

Global AI in Genomics Market, by End User

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• Other End Users

Note: Other end users include contract research organizations and agriculture companies.

Global AI in Genomics Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLA)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-up Approach
    • 2.3.1.2. Top-down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for the Study
• 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

• 4.1. Introduction
• 4.2. Drivers
  • 4.2.1. Rising Focus on Reducing Turnaround Time in Drug Discovery
  • 4.2.2. Increasing Investment in Genomics
  • 4.2.3. Growing Need for and Application of AI in Genomics
• 4.3. Restraints
  • 4.3.1. Limited Availability of Resources for Integration of Artificial Intelligence in Genomics
• 4.4. Opportunity
  • 4.4.1. Emerging Economies
  • 4.4.2. Rising Focus on the Development of Personalized Medicines
• 4.5. Challenges
  • 4.5.1. Ambiguous Regulatory Guidelines for Genomics Software
  • 4.5.2. Poor Security & Storage of Large Volumes of Genome Sequencing Data
• 4.6. Impact of COVID-19

5. Global Artificial Intelligence in Genomics Market, by Offering

• 5.1. Introduction
• 5.2. Software
• 5.3. Services

6. Global Artificial Intelligence in Genomics, by Delivery Mode

• 6.1. Introduction
• 6.2. Cloud & Web-based Mode
• 6.3. On-premise Mode

7. Global Artificial Intelligence in Genomics, by Functionality

• 7.1. Introduction
• 7.2. Genome Sequencing
• 7.3. Gene Editing
• 7.4. Other Functionalities

8. Global Artificial Intelligence in Genomics Market, by Application

• 8.1. Introduction
• 8.2. Drug Discovery & Development
• 8.3. Precision Medicine
• 8.4. Diagnostics
• 8.5. Other Applications

9. Global Artificial Intelligence in Genomics Market, by End User

• 9.1. Introduction
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Academic & Research Institutes
• 9.4. Other End Users

10. Artificial Intelligence in Genomics Market, by Geography

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. U. S.
  • 10.2.2. Canada
• 10.3. Europe
  • 10.3.1. Germany
  • 10.3.2. France
  • 10.3.3. U.K.
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Rest of Europe
• 10.4. Asia-Pacific
  • 10.4.1. China
  • 10.4.2. Japan
  • 10.4.3. India
  • 10.4.4. Rest of Asia-Pacific
• 10.5. Latin America
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America
• 10.6. Middle East & Africa

11. Competitive Landscape

• 11.1. Introduction
• 11.2. Key Growth Strategies
• 11.3. Competitive Benchmarking
• 11.4. Market Share Analysis (2021)
  • 11.4.1. NVIDIA Corporation (U.S.)
  • 11.4.2. Microsoft Corporation (U.S.)
  • 11.4.3. Illumina, Inc. (U.S.)

12. Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, Strategic Developments)

• 12.1. Microsoft Corporation
• 12.2. NVIDIA Corporation
• 12.3. Deep Genomics Incorporated
• 12.4. Fabric Genomics, Inc.
• 12.5. Data4cure, Inc.
• 12.6. Predictive Oncology Inc.
• 12.7. Emedgene Technologies Ltd
• 12.8. Congenica Ltd.
• 12.9. Tempus Labs, Inc.
• 12.10. SOPHiA GENETICS SA
• 12.11. Illumina, Inc.
• 12.12. BenevolentAI Limited

13. Appendix

• 13.1. Questionnaire
• 13.2. Available Customization